Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**5-methyltetrahydrofolate glucosamine salt** is a stable, bioactive form of folate (vitamin B9), where 5-methyltetrahydrofolic acid—the main circulating form of folate in the body—is present as its glucosamine salt for enhanced stability and bioavailability[2][4][6]. Unlike synthetic folic acid, which must be converted in the body, this form is biologically active and can be used directly, including by those with common MTHFR polymorphisms[2][6]. It is primarily used for treating folate deficiency and related indications such as anemia, prevention of neural tube defects, infertility, hyperhomocysteinemia, cardiovascular disease, mild cognitive impairment, and as part of prenatal nutrition and supplementation[1][2][6]. It is most widely known under the brand name Quatrefolic and is present in nutritional supplements and some pharmaceutical formulations[6]. Its mechanism involves direct participation in one-carbon metabolism, including DNA synthesis, methylation, and homocysteine remethylation[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-methyltetrahydrofolate glucosamine salt.